Stoke Therapeutics executive sells over $25k in company stock By Investing.com
© Reuters. Barry Ticho, the Chief Medical Officer of Stoke Therapeutics, Inc. (NASDAQ:), a biotechnology company specializing in pharmaceutical preparations, ...
© Reuters. Barry Ticho, the Chief Medical Officer of Stoke Therapeutics, Inc. (NASDAQ:), a biotechnology company specializing in pharmaceutical preparations, ...
© Reuters. In a recent transaction, Alexander Mark Schobel, Chief Innovation and Technology Officer at Aquestive Therapeutics , Inc. (NASDAQ:), ...
© Reuters. Spero Therapeutics (ticker: NASDAQ:) has announced its financial results for the full year 2023, showcasing a strong balance ...
© Reuters. In a strategic move, Akari Therapeutics (NASDAQ: NASDAQ:) has announced today a private placement agreement with select current ...
© Reuters. DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ:), a biopharmaceutical company specializing in precision oncology, announced today that it ...
© Reuters. In a strategic move, Avenue Therapeutics Inc . (NASDAQ: NASDAQ:) has announced a reverse stock split, as per ...
© Reuters. On Monday, Morgan Stanley initiated coverage on Kyverna Therapeutics Inc (NASDAQ:KYTX), a biopharmaceutical company, with an Overweight rating ...
Cr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant â or takeover target ...
mapo/iStock via Getty Images Aprinoia Therapeutics (APRI), which terminated a merger deal with Ross Acquisition Corp. II (ROSS) last August, ...
Gainers: Larimar Therapeutics (LRMR) +30%. Biodexa Pharmaceuticals ADR (BDRX) +21%. Jin Medical International (ZJYL) +22%. LianBio ADR LIAN+18%. BioXcel Therapeutics ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.